Search research articles
Contact Us
Filters
Showing results (31-40 of 1,070) with videos related to
Page
of 107
Sort By:
Expert Review of Hematology
|
November 8, 2024
Ibrutinib and venetoclax combination therapy for mantle cell lymphoma: are two better than one?
Jian Li, Constatine S Tam
Expert Opinion on Investigational Drugs
|
February 26, 2013
Investigational Janus kinase inhibitors
Constantine S Tam, Srdan Verstovsek
Diabetes Care
|
December 25, 2012
Response to Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610
Charmaine S Tam, Eric Ravussin
China CDC Weekly
|
May 19, 2022
Public Health Control Measures for the Co-circulation of Influenza and SARS-CoV-2 During Influenza Seasons
John S Tam, Yuelong Shu
Hematology/Oncology Clinics of North America
|
June 27, 2021
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Beyond Ibrutinib
Masa Lasica, Constantine S Tam
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering
|
October 23, 2009
Corrosion control in water supply systems: effect of pH, alkalinity, and orthophosphate on lead and copper leaching from brass plumbing
Y S Tam, P Elefsiniotis
Leukemia & Lymphoma
|
February 3, 2015
How best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation?
Constantine S Tam, Stephan Stilgenbauer
Current Hematologic Malignancy Reports
|
May 17, 2020
Management of Ibrutinib Toxicities: a Practical Guide
Masa Lasica, Constantine S Tam
Calcified Tissue International
|
January 1, 1980
Tetracycline labeling of bone in vivo
C S Tam, W Anderson
Anatomical Sciences Education
|
September 10, 2010
Building virtual models by postprocessing radiology images: A guide for anatomy faculty
Matthew D B S Tam
Page
of 107
Search research articles
Search
Showing results (31-40 of 1,070) with videos related to
Sort By:
Page
of 107
Expert Review of Hematology
|
November 8, 2024
Ibrutinib and venetoclax combination therapy for mantle cell lymphoma: are two better than one?
Jian Li, Constatine S Tam
Expert Opinion on Investigational Drugs
|
February 26, 2013
Investigational Janus kinase inhibitors
Constantine S Tam, Srdan Verstovsek
Diabetes Care
|
December 25, 2012
Response to Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610
Charmaine S Tam, Eric Ravussin
China CDC Weekly
|
May 19, 2022
Public Health Control Measures for the Co-circulation of Influenza and SARS-CoV-2 During Influenza Seasons
John S Tam, Yuelong Shu
Hematology/Oncology Clinics of North America
|
June 27, 2021
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Beyond Ibrutinib
Masa Lasica, Constantine S Tam
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering
|
October 23, 2009
Corrosion control in water supply systems: effect of pH, alkalinity, and orthophosphate on lead and copper leaching from brass plumbing
Y S Tam, P Elefsiniotis
Leukemia & Lymphoma
|
February 3, 2015
How best to manage patients with chronic lymphocytic leuekmia with 17p deletion and/or TP53 mutation?
Constantine S Tam, Stephan Stilgenbauer
Current Hematologic Malignancy Reports
|
May 17, 2020
Management of Ibrutinib Toxicities: a Practical Guide
Masa Lasica, Constantine S Tam
Calcified Tissue International
|
January 1, 1980
Tetracycline labeling of bone in vivo
C S Tam, W Anderson
Anatomical Sciences Education
|
September 10, 2010
Building virtual models by postprocessing radiology images: A guide for anatomy faculty
Matthew D B S Tam
Page
of 107